Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an Acyl-CoA chain length-dependent manner.
about
Ceramide synthases at the centre of sphingolipid metabolism and biologyMammalian ceramide synthasesFingolimod for the treatment of neurological diseases-state of play and future perspectivesDefect of insulin signal in peripheral tissues: Important role of ceramideThe cell biology of fat expansionEngineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioningFingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal NeuronsNeurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosisStimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema.FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cellsModulation of ceramide synthase activity via dimerization.Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomersDifferential regulation of autophagy and cell viability by ceramide species.(S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activitySphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteinsSphingolipids: regulators of crosstalk between apoptosis and autophagyA fluorescent assay for ceramide synthase activity.Molecular and functional characterization of the ceramide synthase from Trypanosoma cruzi.Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis.Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.Inhibition of de novo ceramide biosynthesis by FTY720 protects rat retina from light-induced degeneration.Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration.Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertensionSphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.Changes in membrane biophysical properties induced by sphingomyelinase depend on the sphingolipid N-acyl chain.Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells.Sphingosine 1-phosphate signalling in cancer.Oncogenic properties of sphingosine kinases in haematological malignancies.Sphingosine 1-phosphate axis: a new leader actor in skeletal muscle biology.The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.Jaspine B induces nonapoptotic cell death in gastric cancer cells independently of its inhibition of ceramide synthase.Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.Modulation of IL-33/ST2-TIR and TLR signalling pathway by fingolimod and analogues in immune cells.Analysis of sphingolipids in human corneal fibroblasts from normal and keratoconus patients.FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1.FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants.
P2860
Q24609859-7F2E0D38-977D-4338-8B07-0787EFBC06E4Q24633453-4C11B1C7-7F02-474E-8ACB-6B1A23FE4B31Q27026175-6693CE0D-81E5-491E-B191-AA6D64807913Q27690875-853F470E-CBBA-42AB-A482-5F81583DCF93Q28084054-1438C9B2-36CA-44C8-B57C-376430736ACDQ30370009-7BB636D8-24B2-4DBB-B0CB-2EA2970C8F93Q30836800-D46D8941-C975-4C21-943A-22CD885A75EBQ33538932-C9550833-80D0-46D9-AA44-A85055874B78Q33757076-359819AC-622B-4EBC-B0E5-DEE7AD9C44F2Q34162587-B22D713D-0548-4622-B001-763FF9A189DEQ36033185-C047D921-95E6-453E-B905-EA0D319873DCQ36145226-05AA0944-0ECD-4BF0-A8CE-AE38379CF287Q36214943-51E8E122-A0A7-49BA-B370-3A1DCA5BF5C7Q36246895-4FE10ED6-689D-4223-B9AF-12842A75A19AQ36266670-145A44A3-296E-4F5F-96CB-AD4EB59A35F5Q36462123-A66B68CC-F7BC-4DF1-BE05-2A40F2065AB1Q36520280-5B9AE9F5-4CF9-4EF6-BD41-CA610E359CADQ36551253-AB554609-7136-40DF-B480-36D5CDECFB53Q36602177-4353C5F5-529B-488F-BEAA-F92F4246CA66Q36681735-137873EC-7A15-490D-BB8A-A47C155EA319Q36822578-080FF186-650B-47A2-A2ED-B1F2BB08D97BQ36843303-73ADE5FD-E118-474B-ACD5-289A8CFF734BQ37020344-CF66A1D5-40B1-44EF-9BB7-F79EEB010A02Q37056490-03B45FC0-4750-4862-AA8D-F9D3666C4F28Q37396760-27F995E3-603E-457D-8568-2E2ACAB3707EQ37590278-E7039F24-943E-4E62-A81B-3148819F07B4Q37718254-1404CD88-51A0-4099-8D3F-A64A0C3D117DQ37808219-CDC0D9FE-F5E4-4E69-AE6F-5F8D77DCF4C6Q37960383-EB95799F-E965-496F-871D-2F7833D5FE79Q37977171-0460592A-5671-4340-99DE-AFE7F9785E3BQ38092176-0919AC05-6BCD-4626-B334-810C9B69EEE5Q38170107-3C0BBA1F-90B7-4286-95CA-04BCEC9756CAQ38546700-F037A436-E6ED-4706-80D2-2D5FD1068C12Q38701564-4B295DC8-CCB1-4FD5-935A-0372756D0608Q38940670-2B026DC0-BAB6-4F88-9767-532C48771F6EQ38957804-28E5B0B4-386A-40B8-B9E5-2123816B28FBQ38966652-F6EB714F-8BFA-4680-B365-971B985020E0Q38990892-A51D754F-6EDE-4CA4-91F9-DDD986DB94D9Q39049796-12384706-8B67-43B4-9F4B-EDA5DD2574DFQ39624007-02294B7E-EB44-41D1-AECD-F675B47C45AD
P2860
Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an Acyl-CoA chain length-dependent manner.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Ceramide synthesis is modulate ...... chain length-dependent manner.
@ast
Ceramide synthesis is modulate ...... chain length-dependent manner.
@en
Ceramide synthesis is modulate ...... chain length-dependent manner.
@nl
type
label
Ceramide synthesis is modulate ...... chain length-dependent manner.
@ast
Ceramide synthesis is modulate ...... chain length-dependent manner.
@en
Ceramide synthesis is modulate ...... chain length-dependent manner.
@nl
prefLabel
Ceramide synthesis is modulate ...... chain length-dependent manner.
@ast
Ceramide synthesis is modulate ...... chain length-dependent manner.
@en
Ceramide synthesis is modulate ...... chain length-dependent manner.
@nl
P2093
P2860
P356
P1476
Ceramide synthesis is modulate ...... chain length-dependent manner.
@en
P2093
Elad L Laviad
Hyejung Park
Robert Bittman
Sujoy Lahiri
Xuequan Lu
P2860
P304
16090-16098
P356
10.1074/JBC.M807438200
P407
P577
2009-04-08T00:00:00Z